Bullish BLSH
37.58
(2.11)
(5.32%)
as of 25 Sep
- Market cap
- $6.0B
- P/E
- 0.0×
Follow BLSH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+7 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.03 | 0.02 | 0.02 | 0.02 | |
P/FCF ratio |
0.00 | 677.24 | 46.58 | 30.56 | |
P/Operating CF |
(181.55) | 78.23 | 59.40 | 210.47 | |
P/B ratio |
2.13 | 1.47 | 2.00 | 1.44 | |
Price to Tangible BV |
2.18 | 1.51 | 2.07 | 1.50 | |
EV/Sales |
0.03 | 0.02 | 0.02 | 0.01 | |
EV/EBITDA |
124.86 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
1,346.74 | 133.80 | 37.79 | 22.09 | |
EV/FCF |
(564.50) | 536.39 | 40.14 | 23.36 | |
Quick Ratio |
14.39 | 12.06 | 10.68 | 10.68 | |
Current Ratio |
38.78 | 29.28 | 26.42 | 23.52 | |
Net Debt/EBITDA |
(21.67) | 1.75 | 1.20 | 2.97 | |
Debt/Assets |
12.37% | 14.18% | 14.67% | 16.10% | |
Debt/Equity |
0.14 | 0.17 | 0.18 | 0.20 | |
Asset Turnover |
106.68 | 69.95 | 72.33 | 60.15 | |
Operating CF/Net income |
(2.53) | (0.11) | (0.16) | (0.06) | |
Capex/Depreciation |
(1.10) | (8.46) | 1.37 | 0.13 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.11% | 0.07% | 0.09% | 0.17% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
0.01% | 0.01% | 0.01% | 0.02% | |
Graham Net Nets |
0.45 | 0.65 | 0.47 | 0.65 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.91%) | (15.10%) | (18.16%) | (39.35%) | |
Free Cash Flow Yield |
(0.15%) | 0.15% | 2.15% | 3.27% | |
Revenue per Share |
313.00 | 504.23 | 343.18 | 215.25 | |
Operating CF per Share |
(0.35) | 0.48 | 0.60 | 0.11 | |
Capex per Share |
(0.01) | (0.06) | 0.02 | 0.00 | |
Free Cash Flow per Share |
(0.37) | 0.42 | 0.62 | 0.11 | |
Cash per Share |
12.52 | 12.27 | 8.50 | 8.80 | |
Shareholders Equity per Share |
29.90 | 25.82 | 17.88 | 16.22 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
29.90 | 25.82 | 17.88 | 16.22 | |
Free Cash Flow |
(48.62) | 53.80 | 93.97 | 17.16 | |
Working Capital |
4,373.62 | 3,674.15 | 3,057.60 | 2,816.78 | |
Capital Expenditures |
(1.99) | (8.03) | 3.05 | 0.27 | |
Net Current Asset Value |
3,844.06 | 3,145.89 | 2,557.03 | 2,305.15 | |
EV/EBIT |
145.19 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.04% | (0.85%) | (1.12%) | (0.83%) | |
Price to Operating Income |
166.73 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Inventory |
771.77 | 390.03 | 167.65 | 185.50 | |
Average Assets |
2,311.69 | 3,501.96 | 2,994.49 | 3,168.11 | |
Average Common Equity |
2,630.17 | 2,849.49 | 2,333.53 | 2,505.67 |
Columns are period end dates